Your shopping cart is currently empty

(R,R)-LRRK2-IN-7 is an isomer of LRRK2-IN-7, a potent and selective LRRK2 kinase inhibitor with CNS penetrance. It exhibits an IC50 of 0.9 nM and demonstrates over 1000-fold selectivity compared to other kinases, ion channels, and CYP enzymes.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | (R,R)-LRRK2-IN-7 is an isomer of LRRK2-IN-7, a potent and selective LRRK2 kinase inhibitor with CNS penetrance. It exhibits an IC50 of 0.9 nM and demonstrates over 1000-fold selectivity compared to other kinases, ion channels, and CYP enzymes. |
| In vitro | LRRK2-IN-7 (compound 25) is both a substrate for Breast Cancer Resistance Protein (BCRP) in mice and humans and an effective human BCRP inhibitor with a BCRP IC50 of 0.12 μM. |
| In vivo | In a 7-day dose-limiting toxicity study on rats, LRRK2-IN-7 (compound 25) was well tolerated at doses up to 100 mg/kg administered once daily (AUC tot = 330 μM·h). During an acute (2-hour) PK/PD study in rats, LRRK2-IN-7 (compound 25) demonstrated a dose-dependent reduction of LRRK2 pS935 in the rat striatum, with an EC50 of 0.18 nM. |
| Molecular Weight | 414.50 |
| Formula | C24H26N6O |
| Cas No. | 2307277-92-3 |
| Smiles | C(#N)[C@]1(C2(C1)CC2)C=3C=C4N(N=CC4=CC3)C=5C=C(N=CN5)N6C[C@H](C(C)(C)O)CC6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.